Innocoll AG:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Innocoll AG - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10302
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Innocoll AG (Innocoll), formerly Innocoll Holdings Plc is a pharmaceutical company that carries out the development and manufacturing of surgical implants and topically applied healthcare products in the areas of unmet clinical needs. The company’s pipeline product Xaracoll, a bupivacaine HCl collagen-matrix implant and collagen-based delivery technology has been studied in two Phase III clinical trials for postsurgical analgesia as part of multi-modal therapy for patients undergoing hernia repair. Its Xaracoll has been studied to deliver the anesthetic directly at the surgical site and to reduce pain and opioid use after surgery. The company partners with other pharma companies to market its various products. It operates across the US, Ireland, and Germany. Innocoll is headquartered in Athlone, Ireland.

Innocoll AG – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Innocoll AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Innocoll AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innocoll AG, Medical Equipment, Deal Details 10
Venture Financing 10
Innocoll Raises US$1.5 Million In Venture Financing 10
Innocoll Raises US$2 Million In Venture Financing 11
Innocoll Raises US$2 Million In Venture Financing 12
Innocoll Raises US$1.1 Million In Venture Financing 13
Private Equity 14
Gurnet Point Acquires Innocoll for USD209 Million 14
Partnerships 16
Innocoll Enters Into Licensing Agreement With Biomet 3i For CollaCare Dental Products 16
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 17
Equity Offering 18
Innocoll Raises USD40 Million in Public Offering of Shares 18
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 20
Innocoll Raises USD58.5 Million in IPO 21
Innocoll AG – Key Competitors 23
Innocoll AG – Key Employees 24
Innocoll AG – Locations And Subsidiaries 25
Head Office 25
Other Locations & Subsidiaries 25
Recent Developments 26
Financial Announcements 26
Mar 16, 2017: Innocoll Holdings Announces Fourth Quarter and Full-Year 2016 Financial and Operating Results and Provides Corporate Update 26
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Innocoll AG, Medical Equipment, Key Facts 2
Innocoll AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Innocoll AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Innocoll AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Deals By Market, 2012 to YTD 2018 8
Innocoll AG, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Innocoll Raises US$1.5 Million In Venture Financing 10
Innocoll Raises US$2 Million In Venture Financing 11
Innocoll Raises US$2 Million In Venture Financing 12
Innocoll Raises US$1.1 Million In Venture Financing 13
Gurnet Point Acquires Innocoll for USD209 Million 14
Innocoll Enters Into Licensing Agreement With Biomet 3i For CollaCare Dental Products 16
Innocoll Enters Into Licensing Agreement With Flynn Pharma For CollaGUARD 17
Innocoll Raises USD40 Million in Public Offering of Shares 18
Innocoll Raises USD29.89 million in Public Offering of American Depository Shares 20
Innocoll Raises USD58.5 Million in IPO 21
Innocoll AG, Key Competitors 23
Innocoll AG, Key Employees 24
Innocoll AG, Subsidiaries 25

List of Figures
Innocoll AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Innocoll AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Innocoll AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Innocoll AG, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Innocoll AG, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Innocoll AG, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Innocoll AG, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Innocoll AG, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Innocoll AG:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Plansee Holding AG:企業の戦略・SWOT・財務情報
    Plansee Holding AG - Strategy, SWOT and Corporate Finance Report Summary Plansee Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Empire Co Ltd:企業の戦略・SWOT・財務情報
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Lee Memorial Health System:企業の戦略的SWOT分析
    Lee Memorial Health System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Petrel Energy Ltd (PRL):石油・ガス:M&Aディール及び事業提携情報
    Summary Petrel Energy Ltd (Petrel Energy), formerly Orion Petroleum Ltd, is an petroleum exploration, development and production company. The company offers exploitation of petroleum products and produces crude oil using conventional and unconventional methods. It holds tenements in the Norte Basin, …
  • C-Rad AB (CRAD B)-医療機器分野:企業M&A・提携分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments. The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems. Its products include sentinel 4DCT, catalyst HD, …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Genentech Inc-製薬・医療分野:企業M&A・提携分析
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that develops and markets medicines to address serious medical needs. Its clinical development pipeline includes alectinib and Erlotinib for metastatic non-small cell lung cancer; Anti-ST2 for ast …
  • General Dynamics Land Systems Inc:企業の戦略・SWOT・財務情報
    General Dynamics Land Systems Inc - Strategy, SWOT and Corporate Finance Report Summary General Dynamics Land Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Dubai Electricity and Water Authority:発電所・企業SWOT分析
    Dubai Electricity and Water Authority - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informatio …
  • NovoCure Ltd (NVCR):企業の製品パイプライン分析
    Summary NovoCure Ltd (NovoCure) develops and commercializes novel delivery systems for the treatment of cancers of brain, abdomen, and torso. Its proprietary Tumor Treating Fields (TTF) technology platform uses electric fields tuned to specific frequencies for disrupting the division solid tumor can …
  • Follett Corporation:企業の戦略的SWOT分析
    Follett Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Renesas Electronics Corp (6723):企業の財務・戦略的SWOT分析
    Renesas Electronics Corp (6723) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ValiRx Plc (VAL)-医療機器分野:企業M&A・提携分析
    Summary ValiRx Plc (ValiRx) is a biopharmaceutical company that develops technologies and therapeutic options for the treatment of cancer. The company’s products and technology include GeneICE-silencing rebellious genes, GeneICE – BCL-2, VAL201-prostate cancer, NAV3 cancer screening test and VAL401- …
  • RPC Group PLC:企業の戦略・SWOT・財務情報
    RPC Group PLC - Strategy, SWOT and Corporate Finance Report Summary RPC Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Dimension Data Holdings Plc:企業の戦略的SWOT分析
    Dimension Data Holdings Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • iVascular SLU:企業の製品パイプライン分析2018
    Summary iVascular SLU (iVascular) is a designer and developer of advanced medical devices and implants for the treatment of cardiovascular system disorders. The company offers products in the fields of interventional cardiology, endovascular intervention and interventional neuroradiology including d …
  • Cybernet Systems Corporation:企業の戦略・SWOT・財務分析
    Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary Cybernet Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Cayenne Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cayenne Medical Inc (Cayenne Medical), a subsidiary of Zimmer Biomet Holdings Inc, is a soft-tissue reconstruction service provider. The company provides knee and shoulder implant products. It offers products such as aperfix femoral, aperfix II tibial, mirror partial knee, cross fix meniscal …
  • Metropolitan Bank and Trust Company:企業の戦略・SWOT・財務情報
    Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report Summary Metropolitan Bank and Trust Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆